Ultragenyx Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
03.05.24
/
50%
€39.80
Target price
03.05.25
€99.30
Performance (%)
-1.51%
Price
16.05.24
€39.20
Summary
This prediction is currently active. With a performance of -1.51%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 03.05.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Ultragenyx Pharmaceutical Inc. | 3.158% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.40
05.04.24
05.04.24
€98.89
05.04.25
05.04.25
-15.52%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€98.68
27.02.25
27.02.25
-20.97%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.60
15.02.24
15.02.24
€105.84
15.02.25
15.02.25
-12.11%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.20
19.01.24
19.01.24
€104.83
19.01.25
19.01.25
-5.97%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
25.09.23
25.09.23
€107.74
25.09.24
25.09.24
9.88%
16.05.24
16.05.24